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Diabetic foot wounds are commonly colonised by taxonomically diverse microbial communities and may additionally be infected
with specific pathogens. Since biofilms are demonstrably less susceptible to antimicrobial agents than are planktonic bacteria,
and may be present in chronic wounds, there is increasing interest in their aetiological role. In the current investigation, the
presence of structuredmicrobial assemblages in chronic diabetic foot wounds is demonstrated using several visualizationmethods.
Debridement samples, collected from the footwounds of diabetic patients, were histologically sectioned and examined using bright-
field, fluorescence, and environmental scanning electron microscopy and assessed by quantitative differential viable counting. All
samples (n = 26) harboured bioburdens in excess of 5 log
10
CFU/g. Microcolonies were identified in 4/4 samples by all three
microscopy methods, although bright-field and fluorescence microscopy were more effective at highlighting putative biofilm
morphology than ESEM. Results in this pilot study indicate that bacterial microcolonies and putative biofilm matrix can be
visualized in chronic wounds using florescence microscopy and ESEM, but also using the simple Gram stain.
1. Introduction
The aetiological role of biofilms in diabetic wounds remains
poorly understood but their formation is increasingly recog-
nised as a potential barrier to healing [1, 2]. A limited num-
ber of studies have provided evidence for the involvement
of biofilms in chronic wounds using several visualization
techniques including scanning electron microscopy, epiflu-
orescence microscopy [3–5], and confocal laser scanning
microscopy (CLSM) [6–9]. No method for the identification
of wound-associated biofilms has been universally recog-
nized, partly due to the lack of unifying criteria for their
identification that are applicable to a range of visualization
methods.
Whilst various definitions for biofilms have been adopted,
it is generally accepted that they are structured bacterial
communities that are often but not always attached to sur-
faces and which are encased in a self-produced exopolymer
matrix [10–12]. Generally, the identification of biofilms has
relied on the visualization of at least two of the following
three criteria: (i) microbial surface attachment [13–16], (ii)
structured assemblages of microbial cells [15–17], and (iii) the
presence of exopolymer matrix [14, 16]. Scanning electron
microscopy and CLSM, commonly used techniques to visu-
alize biofilms, require specialised apparatus and training and
are typically found in research facilities, whereas bright-field
and epifluorescence microscopy are more widely available in
clinical laboratories.
The current pilot study was conducted as part of a
larger study into the presence of unculturable bacteria in
diabetic foot wounds [18] with the intention of addressing the
commonly stated clinical requirement for a simple means of
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Figure 1: Differential viable counts of selected bacterial groups from
26 chronic wound samples. The lower and upper boundaries of the
boxes represent quartiles 1 and 3, respectively, and horizontal bars
within the boxes represent median values. I represents minimum
outliers and e the maximum outliers. White bars represent samples
from which pathogens [18] were not isolated and black bars samples
from which pathogens were isolated.
identifying biofilms inwound samples. Debridement samples
(𝑛 = 26) were bacteriologically characterised by differential
viable counting and, where sufficient sample material was
available, were subjected to biofilm visualisation techniques.
2. Methods
2.1. Chemicals and Growth Media. Unless otherwise stated
chemicals used were supplied by Sigma (Poole, Dorset, UK).
Dehydrated bacteriological media were obtained fromOxoid
(Basingstoke, Hampshire, UK) and prepared according to
instructions supplied by the manufacturer.
2.2. Collection of Chronic Wound Tissue. This study was
reviewed by the North Manchester Research Ethics Com-
mittee and the Central Manchester University Hospital
Research and Development Department. Reference number:
09/H1006/41, protocol number 1.0. Twenty-six wound tissue
debridement samples were collected from patients with
chronic diabetic foot wounds (defined as being distal to the
medial and lateral malleoli, with a known duration greater
than four weeks), attending a specialist foot clinic. Wound
tissue samples were taken from thewound bed and surround-
ing tissue using a sterile scalpel by the attending clinician
and placed sterile 0.85% (w/v) saline for transportation.
All samples were transported to the laboratory at 2∘C and
processed within 3 h of collection.
2.3. Differential Bacteriological Enumeration and Identifica-
tion. Twenty-six tissue samples were processed as previously
described [18]. Bacterial identificationwas based upon colony
morphology, Gram staining, catalase reaction, latex coagu-
lase reaction tests, and Lancefield group reaction to identify
beta-haemolytic streptococci (Prolex Streptococcal grouping
latex kits, Pro-Lab Diagnostic, Cheshire, UK) and growth on
Brilliant UTI media.
2.4. Tissue Sectioning. Residual chronic wound tissue from
four samples (which were of sufficient quantity for multiple
microscopic analyses) were divided transversely (50 : 50)with
a sterile scalpel and one section was embedded in optimal
cutting temperature (OCT) embedding matrix and frozen at
–80∘C for ≥24 h. The remaining tissue sections were placed
in a sterile Bijou bottle and transported immediately for
ESEM imaging. To produce slide-mounted tissue sections
to visualise microcolonies and biofilm architecture, OCT-
embeddedwhole tissue samples were sectioned to a thickness
of 5 𝜇m and mounted on Superfrost Plus microscope slides
(Fisher Scientific, Leicestershire, UK) using a ShandonAS260
manual cryostat. Tissue sections were subjected to Gram
staining and fluorescence in situ hybridisation (FISH).
2.5. Fluorescence In Situ Hybridisation, Fluorescent Probes,
and Staining to Differentiate Bacteria, Biofilms, and
Tissue. Slide-mounted tissue sections were fixed in
4% paraformaldehyde for 3 h and then subjected to a
prepermeabilization step, consisting of lysozyme enzymatic
buffer (100mMTris HCl [pH8], 50mMEDTA, and lysozyme
[5mg/mL]), for 4 h at 45∘C. Slides were then washed in wash
buffer consisting of 0.9M NaCl and 20mM Tris and air-
dried. Slides were then incubated in FISH buffer containing
50% formamide, 0.9M NaCl, 20mM Tris, 0.01% SDS (w/v),
and 50 ng of the general eubacterial probe (EUB 338)-cy3
probe-GCT GCC TCC CGT AGG AGT [19] (Ex. 550 nm,
Em. 570 nm), incubated in a humidity chamber at 55∘C for
4 h and then washed with wash buffer. Once dried, slides
were exposed to 10 𝜇L/mL working concentration of the
carbohydrate-binding lectin, Concanavalin A conjugated
Alexa Fluor 488 (Invitrogen, Paisley, UK) (Ex. 495 nm,
Em. 643 nm) for 1 h at room temperature to aid in the
visualization of putative biofilms. Concanavalin A binds to
internal and nonreducing terminal alpha mannosyl groups,
a common component of oligosaccharide of glycoproteins
found in biofilms [20, 21]. Finally, to differentiatemammalian
cells, the nucleic acid stain Hoechst 33252 (2𝜇g/mL) (Ex.
350 nm, Em. 460 nm) (Sigma, Poole, Dorset, UK) was added
for 1 h at room temperature [7]. All staining procedures
were completed in the dark. Tissue sections were also
Gram-stained as per standard protocols.
FISH images were captured using an Olympus BX51
upright microscope using a 60x and 100x objective and cap-
tured using a Coolsnap ES camera (Photometrics, AZ, USA)
through MetaVue Software (Molecular Devices, CA, USA).
Specific band pass filter sets for DAPI (Ex. BP365/12 nm,
Em. LP397 nm), FITC (Ex. BP450–490 nm, Em. BP515–
565), and Texas red (Ex. BP546/12 nm Em. LP615 nm) were
used. Gram-stained images were visualized using a Zeiss
Axioscop 2microscope,Axiocam, andAxiovisionVersion 4.8
(Carl Zeiss Ltd., Herefordshire, UK). All images were then
processed using ImageJ (http://rsb.info.nih.gov/ij).
2.6. ESEM of Chronic Wound Tissue. Chronic wound tissue
was placed in a sterile Bijou and transported immediately
for ESEM imaging. ESEM of chronic wound tissue samples
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Figure 2: Images acquired from Sample 1. (a) and (b) are replicate images from Gram-stained sections; (c) and (d) (replicates) have been
visualized using a combination of FISH (red), to indicate eubacteria, ConA (green) to indicate biofilm matrix, and other ConA-reactive
material, and with Hoechst 33252 (blue) for the detection of nucleic acids. (e) and (f) show replicate ESEM images. Presumptive bacterial
microcolonies and biofilm matrix have been indicated by arrows.
was performed using a FEI Quanta 200 environmental scan-
ning electron microscope under a low vacuum (<0.75 Torr)
permitting inspection of putative biofilm structures and
microcolonies whilst conserving the hydrated state of the
sample.
3. Results
3.1. Viable Bacterial Counts from Wound Samples. All 26
tissues samples harboured aerobic and facultative anaerobic
species at cell densities equal to or greater than 5 log
10
CFU/g
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Figure 3: Images acquired from Sample 2. See legend to Figure 1.
of tissue, as shown in Figure 1 andTable 1. Of the four samples
which were subjected to visualisation techniques, the total
anaerobic, aerobic and viable counts of staphylococci were
within two standard deviations of themean of the total popu-
lations sampled. Samples 1 and 2 harboured streptococci and
Sample 4 was the only tissue sample from which coliforms
were isolated, (Table 1).
3.2. Biofilm Visualization. Figure 2 shows the stained and
imaged chronic wound sections from Sample 1. Gram
staining, the use of a eubacterium specific FISHprobe Figures
2(c)-2(d), and ESEM Figures 2(e)-2(f) analysis indicate the
presence of bacterial microcolonies embedded within and/or
upon surfaces of wound tissue. Figure 3 similarly shows
imaged chronic wound sections from Sample 2, as does
Figure 4 for Sample 3. Bacterial infiltration into internal
portions of the tissues tissue sections is not apparent Figures
4(c)-4(d). Images derived from Sample 4 are shown in
Figure 5. Whilst bacteria have been indicated in this sample
by FISH, Gram staining showed only putative bacterial cells
and, furthermore, discrete bacterial cells were not revealed by
Journal of Diabetes Research 5
Table 1: Differential viable counts of selected bacterial groups from the four imaged samples.
Sample Total:
Aerobic count Anaerobic count Staphylococci Coliforms Streptococci
1 10.31 9.07 8.93 ND 7.73
2 10.46 10.49 5.93 ND 10.40
3 7.28 7.33 7.24 ND ND
4 8.39 8.36 ND 8.49 ND
Mean∗ (𝑛 = 26) 8.15 (1.30) 7.87 (1.72) 7.09 (1.77) 3.20 (4.27) 3.37 (3.90)
Values are log
10
CFU/g. Samples 1–4 correspond to the numbered imaged samples in Figures 2–5. ∗refers to mean values from the 26 samples for which full
data is presented in Figure 1 (standard deviations are given in parentheses). Pseudomonas was not detected in samples 1–4 and was only detected in one of the
26 samples (at 4.7 log
10
,CFU/g).
in ESEM. It is possible, however, that, in the latter case, cells
may have been obscured by biofilm matrix material.
Based on localization of reactive material, the utility
of ConA and Hoechst 33252 as specific biofilm indicators
is limited by the reactivity of structures associated with
host cells. However, it is likely that Con-A-reactive material
adjacent to bacterial microcolonies (as indicted by the FISH
probe) is biofilm matrix. This is particularly evident in
Figures 2 and 3.
4. Discussion
The taxonomically diverse microbial communities which
occur in diabetic foot wounds may include both aerobic
and anaerobic organisms many of which are potentially
pathogenic [22, 23]. The role that such organisms play in
impeding healing has been previously documented [22–26].
However, the aetiological role of bacterial biofilms in diabetic
foot wounds remains poorly understood, although they are
becoming recognised as a potential impediment to healing
[1, 2]. As such, there is an increasing clinical need to identify
biofilms in these wounds. In the current study, quantitative
and diagnostic culture techniques were used to measure
wound bioburdens, whilst tissue samples were also subjected
to bright-field, epifluorescence, and ESEM to identify struc-
tures associated with the biofilm phenotype. Each method
was selected to represent biofilm visualization methods com-
monly reported in the literature and their presumed ability
to identify at least two of the following three criteria: (i)
microbial surface attachment, (ii) structured assemblages of
microbial cells, and (iii) the presence of exopolymer matrix.
According to previous reports, images of sections stained
using hematoxylin and eosin, and Gram-stained biofilms,
for example, readily may reveal microcolonies attached to
tissues but reportedly fail to recognize the exopolymermatrix
[5, 27]. The application of epifluorescence microscopy and
CLSMhowever allows for the specific staining of the exopoly-
mer matrix [21, 28], but not all studies using fluorescence
microscopy have adopted this approach [7, 25].
A limitation of biofilm matrix staining using a
carbohydrate marker such as the (fluorescently labeled)
carbohydrate-binding lectin, Concanavalin-A, is the fact
that reactive materials are also commonly associated with
mammalian cells. It is, therefore, important to consider the
location of reactive material. The feasibility of this approach
may be enhanced by using FISH-probes for bacteria and a
nucleic acid stain such as Hoechst 33252.
When exploring biofilms using scanning electron
microscopy, a high level of resolution and detail can be
obtained, potentially revealing biofilm-specific morphology,
but also individual cells and their spatial location.
Exopolymer matrix is amorphous material which may
appear as a layer covering the biofilm, or as a fibrousmaterial.
Preparation of the sample for SEM involves dehydrating
the sample which can affect the overall morphology of the
biofilms and the appearance of the biofilm matrix. These
considerations can partially be overcomewith the application
of ESEM or cryo-SEM which preserve the hydrated state of
the biofilm.
In the present study, examination of slide-mounted,
Gram-stained tissue sections revealed microcolonies
attached to tissues which are indicative of the biofilm
phenotype. These microcolonies comprised Gram-positive
cocci (Samples 1–3), which corresponds to the organisms
isolated by culture, coagulase negative staphylococci (Sample
1), and Staphylococcus aureus from Samples 2 and 3.
Fluorescence microscopy of slide mounted tissue sections
using FISH produced images which generally agreed with
those obtained using Gram staining, such as microcolonies
in Samples 1–3 and the low numbers of bacilli in Sample 4. An
additional benefit of fluorescence microscopy is the option
to detect biofilm matrix using a fluorescent probe. All four
samples showed evidence of exopolymer matrix using the
Concanavalin A conjugated Alexa Fluor 488 probe. Biofilm
matrix was identified as distinct material encasing stained
bacterial cells. Interestingly, combining tissue sectioning
and simple staining techniques, microcolonies and bacterial
exopolymer could be readily identified, with the extent of
bacterial infiltration discernible from the depth of each slide
section. Whilst evidence of biofilm involvement could be
found in all tissues examined, sectional analysis of tissues
suggested that biofilms were limited to surface tissue sections
with little or no evidence of bacteria or matrix found at
depths greater than 20𝜇m.
The tissue samples were imaged further using ESEM. To
conserve their hydrated state inspection of tissue surfaces was
performed using an ESEM under a low vacuum (<0.75 Torr).
Whilst ESEM is a method which requires access to the
specialised equipment and training to ensure conservation
of biofilm architecture and tissues, the images generated
6 Journal of Diabetes Research
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Figure 4: Images acquired from Sample 3. See legend to Figure 1.
generally agreed with those gathered using the less com-
plex methods using Gram and fluorescent staining, with
microcolonies and/or amorphous substances (indicative of
biofilms) identified in all samples.
The three visualisation techniques involved staining,
fluorescence, and high-resolution microscopy to identify
structures typical of the biofilm phonotype. Whilst the
data presented represent a relatively small sample size, the
outcomes of eachmethodwere broadly congruent. Since each
method detects at least two of the three criteria (i) microbial
surface attachment [13–16], (ii) structured assemblages of
microbial cells [15–17], and (iii) the presence of exopolymer
matrix [14, 16], biofilms can be detected and, perhaps more
significantly, this can be achieved using techniques such
Journal of Diabetes Research 7
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Figure 5: Images acquired from Sample 4. Putative biofilm matrix is indicated by arrows. See legend to Figure 1.
as Gram staining and fluorescent microscopy which are
comparatively cost effective and simple to conduct, requiring
equipment that can be found inmany diagnostic laboratories.
The growing interest in the role biofilms play in chronicity
and impaired healing of diabetic wounds has led to an
increased clinical requirement for a simplemeans of identify-
ing biofilms in wound samples. More readily available meth-
ods such as Gram staining and bright-field microscopy can
efficiently detect microcolonies associated with the biofilm
phenotype and may therefore be of use for the identification
of biofilms where expediency and cost-effectiveness are
required.
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